Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Marsi Bionics has developed and commercialized the world’s first pediatric overground exoskeleton for children with neurological and neuromuscular diseases. Clinical feedback highlights improvements in strength, posture, breathing, motor skills, cognitive engagement, and social integration among users. The company’s MAK Active Knee orthosis supports post-surgical and neurological rehabilitation of adults. No formal drug-like clinical trial results; outcomes are based on device performance and patient/clinician reports.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marsi Bionics.